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MOVING FROM RESCUE TO PREVENTION: REAL WORLD EVIDENCE OF REDUCTION 
IN IV ANTIBIOTIC REQUIREMENT FOLLOWING IMPROVEMENT IN ADHERENCE TO 
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Background  
Adherence to preventative nebulised therapy is associated with better health and lower costs for 
rescue treatment. However, adherence with nebulised treatment is generally poor and there is 
currently no systematic adherence intervention for people with CF. The Sheffield Adult CF centre 
has embarked on various pilot projects in this area, culminating in an NIHR programme grant 
awarded in 2014 to develop such a systematic adherence intervention. We hypothesised that the 
pilot projects would have improved the adherence levels and health outcomes among people with 
CF receiving care at the CF centre. 
 
 
Objectives  
To determine overall change in nebuliser adherence and health outcomes among the cohort of 
people with CF in Sheffield from 2013 to 2014. Methods Demographic data, spirometry, BMI, 
annual total intravenous antibiotics days and prescription details were obtained by reviewing patient 
notes. Adherence was measured with I-neb nebuliser and calculated as a percentage of the agreed 
regimen between clinicians and people with CF. People on ivacaftor or with previous lung 
transplantation were excluded from this analysis. 
 
 
Results  
15 people were excluded from the analysis for both years. The cohort increased from n = 166 in 
2013 to n = 170 in 2014, with a similar increase in the number of people with Ineb data for 3 
months (n = 83 in 2013, n = 85 in 2014).  
 
Median nebuliser adherence 
improved from 40.5% in 
2013 to 49.5% in 2014.  
 
The median FEV1 remained 
stable at 79% while BMI 
improved slightly from 22.0 
in 2013 to 22.7 in 2014.  
 
The total IV days reduced by 
657 from 3970 in 2013 to 
3313 in 2014; a potential 
saving of around £156,000. 
 
 
 
 
Conclusion  
Although adherence remains a challenging issue, these data suggest the potential of benefits of 
improved adherence. More work will be needed to examine the adherence data in more detail and to 
collect further longitudinal data to determine if there is a clear trend of improvement. 
